Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Kampo medicine can help treat general fatigue from long COVID.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Androgenetic alopecia severity does not affect COVID-19 severity.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Combining two treatments for hair loss works better than using just one.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Post-COVID-19 hair loss is likely due to stress and inflammation.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

COVID-19 can cause temporary hair loss due to stress and inflammation.

COVID-19 can cause hair loss, loss of taste and smell, skin changes, and eye problems.

The document's conclusion cannot be summarized because the content is not available to parse.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Aesthetic medicine needs clear ethical guidelines to ensure patient well-being and safety.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Teledermatology is crucial and effective for remote skin care in India.